Objective: This study examines the relationship between tea consumption and colon cancer risk in the US population. Design: Data from the NHANES I Epidemiologic Follow-up study (NHEFS) were used to examine the hypothesis. Cox proportional hazard models were used to examine the hypothesis of a protective effect of frequent tea consumption on colon cancer occurrence. Setting: Due to differences in the precision of the exposure data, we analysed two cohort periods based on the NHEFS. Cohort I was based on the survey conducted at the NHEFS baseline and Cohort II began at the first follow-up. Subjects: After excluding non-incidence cases and cases lost to follow-ups, there were 2359 tea users and 6498 non-tea users at baseline and 7656 tea users and 4514 non-tea users at the first follow-up. Results: After adjusting for confounders, the relative risks of colon cancer are 0.57 (95% confidence interval (CI) 0.42, 0.78) and 0.59 (95% CI ¼ 0:35; 1.00) for subjects who consumed #1.5 cups and .1.5 cups per day, respectively, compared with nontea users in Cohort II. Although more women consumed tea and the mean intake was higher, the preventive effect of tea consumption on colon cancer was found predominantly in men. The relative risks of colon cancer are 0.41 (95% CI ¼ 0:25; 0.66) for men who consumed #1.5 cups day 21 and 0.30 (95% CI ¼ 0:09; 0.98) for .1.5 cups day 21 of tea consumption (P-value for trend ,0.01). No significant results were found in Cohort I. Conclusions: This study suggests an inverse association between colon cancer risk and habitual tea consumption.
Colon cancer is the second leading cause of cancer death in the United States 1 -3 . The American Cancer Society estimates that about 93 800 new cases of colon cancer will be diagnosed in the year 2000 and account for about 8% of all newly diagnosed cancers 3 . The identification of risk factors for colon cancer and subsequent intervention against the risk factors, especially in the at-risk population, hold greater promise for achieving the goal of decreasing mortality rates from this disease than does treatment.
Although a genetic component is well established, 85% of colon cancer cases are still considered 'sporadic'. In addition, indirect evidence, based largely on the differences in cancer rates across countries 4 and changes in rates over time and among migrants 5 -7 , implies that environmental factors -diet in particular -are also important. A search for the dietary risk factors for colon cancer is warranted in order to reduce colon cancer incidence and the healthcare costs of this disease.
Tea has a history of human use of over 4000 years and is the second most commonly consumed beverage in the world. There are emerging data on the anti-carcinogenic benefits of tea consumption. In vitro experiments and in animal models have shown tea to be an effective agent against chemically induced tumorigenesis, affecting induction, tumour size and metastases 8 -11 . Epidemiological study results, however, have been inconsistent in showing the beneficial effect of tea consumption on cancer prevention.
The First National Health and Nutrition Examination Survey (NHANES I) Epidemiologic Follow-up Study (NHEFS) is a prospective cohort study with a probability sample of men and women from the non-institutionalised US population and includes a wide range in age, socioeconomic status and ethnicity. This study uses the NHEFS data to examine whether there is an inverse association between habitual tea consumption and colon cancer risk over an approximately 20-year follow-up period.
Methods

Study population
Detailed descriptions of NHANES I and NHEFS have been published previously 12 -18 . In brief, NHANES I was conducted by the National Center for Health Statistics from 1971 to 1975. Baseline data on sociodemographic characteristics, medical history, diet, and biochemical and anthropometric measures were collected from a US national probability sample of non-institutionalised persons aged 25 to 74 years. Population subgroups thought to be at 'nutritional risk' were over-sampled. Four waves of follow-up for the 14 407 subjects who underwent the medical examination were conducted in the NHEFS during 1982 -84, 1986, 1987 and 1992 . Those who had died were followed up by proxy interview. Of the 14 407 participants eligible for follow-up, 13 291 (92.2%) were successfully traced through 1992. Death certificates were coded according to the ninth revision of the International Classification of Diseases (ICD-9).
Colon cancer cases
Cancer morbidity was self-reported in four follow-up interviews; cancer mortality was ascertained through proxy interview and information from the National Death Index. In rare situations where the year of first cancer diagnosis was not available, the midpoint between two interviews was used as the year of cancer incidence. The cause of death was validated by referring to the primary cause of death listed on the death certificate by the NCHS. International Classification of Diseases ICD-9-CM code 153 was used to identify colon cancer morbidity as the first cancer incidence other than skin cancer. Cancer cases that reported having had other cancers previously were excluded from the analysis. If subjects reported multiple cancers in the same year and colon cancer was among the cancers, colon cancer was selected as the primary cancer incidence. Overall, colon cancer cases were determined primarily from the morbidity information. If subjects died of colon cancer but never reported colon cancer morbidity, the subjects were assigned as colon cancer cases and the time of death was identified as the cancer incidence. The follow-up time of cases was calculated by subtracting the month and year of the baseline interview from the mid-year of the 'incidence' of colon cancer. Similarly, for lost subjects, the follow-up time was estimated as the total number of months between baseline interview and the time of censoring. The censoring time was either the time of dropout (loss to follow-up or cancer of other sites) or the end of the study in July 1993.
Tea consumption
Tea consumption status was based on a 24-hour dietary recall data and one question on consumption of tea and coffee in the baseline survey (1972-74) and the food-frequency questionnaire solicited in the 1982 -84 follow-up survey. The baseline questionnaire did not distinguish between tea and coffee consumption. Therefore, if subjects reported tea drinking in the 24-hour dietary recall regardless of the response to the single question in the questionnaire, the amount of tea consumption is used as daily tea intake. However, if subjects responded 'yes' to the question but reported no coffee consumption in the 24-hour recall, the average amount of tea consumed by tea users in the NHEFS is used to define the amount of tea consumption. The foodfrequency questionnaire conducted in 1982-84 contained much more detail about tea drinking practices and frequency of consumption. We are able to directly calculate the amount of daily tea consumption.
Analytic cohorts
Two distinct analytic cohorts were defined. Cohort I was based upon the initial interview with its baseline . Cohort II included all persons free of cancer until the first follow-up (1982-84) of the NHEFS. Cohort I was followed for approximately 20 years ðn ¼ 14 407Þ; Cohort II was followed for approximately 10 years ðn ¼ 10 220Þ:
Dietary intakes
Dietary records were obtained from a single 24-hour recall interview at the baseline survey for 10 220 members of the NHEFS cohort. Intakes of 13 nutrients for the foods consumed in the NHANES I baseline survey were calculated by the NCHS. Intakes of total calories, calcium, total fat and dietary fibres were included as covariates to assess possible confounding effects of these on the tea-colon cancer relationship.
Other covariates Sociodemographic variables obtained from the baseline survey (age, education, race, gender and poverty index) were included in the examination as possible confounders or effect modifiers. Questions on alcohol consumption were asked at the baselines of both cohorts. Non-drinkers were defined as those who reported no alcohol consumption in the past year. The average number of drinks consumed per week was derived by multiplying the frequency of drinking by the average amount usually consumed. The calculation of body mass index (BMI, kg m 22 ) was based on self-reported weight and height at baseline. In addition, subjects were asked at the 1982 -84 and 1992 interviews whether any close family members (parents/siblings/children) had cancer and, if so, the types of cancer. The information from both waves of interviews was then combined to create the variable for familial colon cancer history. Aspirin use over the 30 days prior to the baseline interview was entered as a dichotomous (yes/no) variable; the use of vitamin or mineral supplements in the past month was also assessed and coded as yes/no. Three levels of physical activity were estimated based on the selfreported amount of physical activity engaged in.
Exclusions
Among the eligible subjects, 172 subjects had either metastasised colon cancer or previously diagnosed cancer before the first follow-up of NHEFS in 1982 -84. As a result, 219 colon cancer cases and 9792 non-cases were entered into the study analyses.
Statistical analyses
Cox proportional hazard models, with adjustment for potential confounders (age, race, gender, education, aspirin use, vitamin/mineral use, body mass index, physical activity, dietary intakes of calories, fat, fibre and calcium, and family history of colon cancer), were used to estimate the relationship between tea consumption and the relative risk of colon cancer. Vitamin and mineral use, aspirin use, alcohol consumption and baseline smoking status were missing for some subjects. Covariate inclusion was based on whether inclusion of a covariate changed the coefficient for the main variable by more than 10%. Family history of colon cancer, vitamin and mineral use, physical activity and smoking at baseline were thus not included in the final models. Both continuous and categorical tea consumption variables were used to model colon cancer risk. Gender and race were assessed for possible effect modification.
Results
The summary demographic characteristics of the NHEFS Cohorts were stratified by tea consumption status (Table 1) . After the exclusion of subjects with incomplete information, this study consisted of 3884 subjects reporting no tea drinking at both baseline (1971-75) and first follow-up (1982-84), 6532 subjects reporting tea consumption at either baseline or first follow-up, and 1919 subjects reporting tea consumption in both surveys. The mean age was significantly higher in non-tea users than in tea users ðP , 0:01Þ: Men were more likely to be non-tea users than women in this study. A higher percentage (57.9%) of non-tea users had less education (,12th grade) than users (37.5% and 34.5% for short-term and long-term users, respectively). Long-term tea users were more likely to be white, had family history of colon cancer, and take a vitamin/mineral supplement. Tea consumption at baseline and the risk of colon cancer adjusted for confounders are summarised for the NHEFS Cohort I ( Table 2 ). Although there is generally an inverse relationship between colon cancer risk and whether subjects consume tea or not, the relationship did not achieve statistical significance when the data for men and women were combined or analysed separately. When the association between tea consumption and colon cancer risk was examined based on the amount of tea consumed each day, a non-significant inverse trend * Subjects who reported no tea consumption in both baseline and first follow-up are coded as 'non-tea users'; subjects who consumed tea either at baseline or first follow-up are coded as 'short-term tea users'; subjects who consumed tea at both surveys are considered as 'long-term tea users'. † Tea consumption information was not available for 21 cases and 2051 non-cases. ‡ Physical activity information was not available for 10 subjects.
ðP ¼ 0:15Þ was observed in men but not women in this study.
The association between tea consumption and colon cancer risk in the NHEFS Cohort II was also examined (Table 3) . When data from men and women were combined, individuals reporting tea consumption showed significantly reduced risk for colon cancer compared with non-users (relative risk (RR) 0.58, 95% confidence interval (CI) 0.43, 0.78). The association remained significant when tea consumption was examined based on the number of cups of tea consumed each day. In addition, a significant inverse trend ðP , 0:01Þ was observed for the association. When men in the NHEFS Cohort II were examined alone, the risk reduction for tea consumption was even greater. A strong dose -response relationship ðP , 0:001Þ was observed, with approximately 59% and 70% reduced colon cancer risk for those consuming 0-1.5 cups and for those consuming more than 1.5 cups per day, respectively, compared with men who did not drink tea.
Although women who consumed tea demonstrated a reduced relative risk of colon cancer compared with women who did not drink tea, the association did not reach statistical significance (RR ¼ 0:69; 95% CI ¼ 0:46; 1.04).
Discussion
Findings from epidemiological studies of the relationship between tea consumption and colon cancer risk have been inconsistent. These studies have found tea to be either preventive 19 , a risk factor 20 , or to have no association with colon cancer 21 . The current study found a significantly reduced risk for habitual tea consumers when compared with non-users in the NHEFS Cohort II. In the male population in the study, the inverse doseresponse relationship was significant. The risk reduction measured in the NHEFS 1982-84 survey reached as high as 70% for men who consumed more than 1.5 cups of tea each day. The relationship for women in the NHEFS Cohort II and for the entire NHEFS Cohort I did not reach statistical significance.
The NHEFS has some powerful advantages as a cohort. Since it reflects the underlying diversity of the US population as a whole, it has greater power to detect an effect than a more homogeneous cohort. In addition, the results from this cohort have great external validity to the US population. Concerns about recall bias are excluded in a cohort design as dietary data are collected prior to the disease diagnosis. The relatively large sample size and the successful follow-up rate of approximately 90% provide an excellent data source for the hypotheses in question. However, there are some limitations to the use of the NHEFS data. The questionnaire at baseline asked whether subjects drank tea or coffee in one question. Thus it is unclear whether subjects who had a positive answer to this question were tea drinkers, coffee drinkers or drinkers of both coffee and tea. Besides, no specific information was obtained regarding either the frequency or the portion of the beverage consumed. In order to avoid misclassification bias, the information was cross-checked with the 24-hour dietary recall data. If an individual reported drinking any coffee but not tea on the particular day of recall, the subject was then categorised as a non-user of tea. If an individual was determined as a tea user in the question but no specific amount of consumption was given in the recall data, the average daily consumption amount among tea users was assigned to that subject. These two approaches to code tea consumption data at baseline aim to minimise possible differential misclassification. Twenty-four hour recall is a valuable tool for capturing frequent (daily) tea consumption but is less reliable in appropriately characterising infrequent consumers. Therefore, the analyses of baseline tea consumption in this study may not capture those who consumed both tea and coffee infrequently in the baseline period, or even tea drinkers who happened not to drink tea at the particular day of the 24-hour dietary recall assessment. As a result, the estimates for the relationship between tea and colon cancer may be biased towards the null and thus weaken the observed associations.
On the other hand, tea consumption in the NHEFS Cohort II was assessed using a semi-quantitative foodfrequency questionnaire (FFQ) for average dietary intakes over the past year. Tea consumption and coffee consumption were queried in separate questions and the frequency, as well as portion size, were assessed separately. The FFQ provides a better quantitative estimate for habitual tea consumption than the 24-hour dietary recall used in the NHEFS Cohort I. The results of this study not only reflect the ability of the FFQ to quantify the habitual tea consumption, but also demonstrate a consistent and stronger preventive effect of tea consumption on colon cancer compared with findings from Cohort I. This is a secondary data analysis study. It is impossible for us to assess the validity of tea consumption data. There is no way to compare the findings from Cohort I and Cohort II to determine which one is more valid. It is, however, clear that the method used to assess tea consumption in Cohort II is a better instrument to capture habitual dietary intake 22 -25 . Besides, findings from both cohorts show an inverse relationship between tea consumption and colon cancer risk. In addition, categorical analysis based on tea consumption pattern over the two-survey period, as ordered in Table 1 , suggests that there are 86% ðP ¼ 0:04Þ and 42% ðP ¼ 0:15Þ increased risk for men and women, respectively, when comparing subjects who never drank tea with long-term tea drinkers (data not shown). This finding indirectly supports that the Cohort II results may be more representative of the effect of tea consumption on colon cancer risk.
Data from laboratory studies suggest that specific types of tea have different impacts on carcinogenesis 26, 27 . Unfortunately, neither cohort of the NHEFS assessed various types of tea. Lacking information regarding the types of tea used, the results of this study might be prone to misclassification. Given that even the NHANES III (1988-94) dietary assessment data show minimal green tea consumption in the US population, it is reasonable to assume that the majority of the population in the USA consumed black tea at the time that the NHEFS surveys were conducted in the early 1970s and again in the early 1980s. Therefore, the degree of misclassification for types of tea consumed should be minimal. The results seen in this study should be mostly from the effect of black tea.
It is not clear why the preventive effect of tea consumption is stronger in men than women in this study. One explanation may be that the women in this study are significantly younger than are the men. Besides, the risk of colon cancer is lower for women than for men to start with 28 . The non-significant result observed in women may simply be the result of the lower susceptibility to colon cancer risk among this particular population. On the other hand, this study found that the percentage of alcohol users is higher in women than in men in both cohorts. This finding is contradictory to the finding from another US study 29 . It is possible that men in this study may be more likely to underreport alcohol drinking than women 30 . Since alcohol drinking has been linked to colon cancer risk 31 -34 , insufficient control for alcohol use may bias the study results. The finding of a higher percentage of women reporting drinking alcohol is consistent across both baseline and first follow-up surveys. The finding of a stronger effect of tea on colon cancer in Cohort II should not be attributed as the result of residual confounding due to insufficient controlling of the self-reported alcohol consumption information.
This study excluded subjects who developed cancer before the study for each of the cohorts. However, Cohort II subjects may have modified their lifestyle and health behaviour simply because they are enrolled in the study. Given the lengthy latent period for colon carcinogenesis, the information collected at the first follow-up survey used as 'baseline' data for Cohort II may have reflected the modified behaviour, especially after close to 10 years in the study since they entered the study in the early 1970s. Fortunately, NHEFS did not actively contact study participants between each survey, as did another prospective cohort study 35 . Subjects did not receive updated health information from the NCHS. Besides, tea consumption was not considered beneficial during the survey period in the 1970s and early '80s. Subjects were not likely to modify their health behaviour towards tea drinking by simply being in the follow-up study. The direct effect from participation should be minimal. However, residual confounding effects from other lifestyle factors may exist.
In conclusion, this study found a significant inverse association between habitual tea consumption and colon cancer risk among men. The association is less strong in women. Infrequent tea consumption based on a single 24-hour dietary recall with a longer follow-up period did not show significant association. Although the study results should be interpreted cautiously given the nature of the study limitations, an apparent colon cancer prevention effect was seen for men who consumed more than 1.5 cups of tea per day. Considering the increased popularity of the consumption of both green and black tea, this study, along with experimental data, suggests that the preventive effect of tea on colon cancer merits further study.
